According to Blue Shield Optoelectronics's announcement, the cumulative deviation value of the company's stock price increase exceeded 100% from August 10 to 13, 2026, which is an abnormal and serious abnormal fluctuation. After self-inspection, there were no important matters that should be disclosed, and the controlling shareholders, actual controllers, etc. did not trade the company's shares during this period. The company's operating performance faced challenges. In 2025, revenue was 399 million yuan, down 34.53% year on year, net loss was 89 million yuan, down 1468.72% year on year; Q1 revenue in 2026 was 88 million yuan, down 13.20% year on year, and net loss was 190 million yuan, down 271.99% year on year. Furthermore, the company's rolling price-earnings ratio is negative, and there are risks such as approval and integration of proposed asset transactions.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.